🕵️ Agenus Inc ($AGEN)
SEC insider & ownership activity, last 12 months · CIK 1098972 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Raymond Debbane | 10.0% | 13G | Jul 17, 2026 | filing ↗ | |
| RA Capital Management, L.P. | 9.9% | 13G | Jul 20, 2026 | filing ↗ | |
| Peter Kolchinsky | 9.9% | 13G | Jul 20, 2026 | filing ↗ | |
| Rajeev Shah | 9.9% | 13G | Jul 20, 2026 | filing ↗ | |
| RA Capital Healthcare Fund, L.P. | 9.9% | 13G | Jul 20, 2026 | filing ↗ | |
| Invus Public Equities, L.P. | 8.8% | 13G | Jul 17, 2026 | filing ↗ | |
| Invus Public Equities Advisors, LLC | 8.8% | 13G | Jul 17, 2026 | filing ↗ | |
| Invus Global Management, LLC | 8.8% | 13G | Jul 17, 2026 | filing ↗ | |
| Siren, L.L.C. | 8.8% | 13G | Jul 17, 2026 | filing ↗ | |
| Blackrock, Inc. | 6.0% | 13G | Jul 27, 2026 | filing ↗ | |
| Zynext Ventures PTE Ltd | 5.9% | 13D | Jan 15, 2026 | filing ↗ | |
| Zydus Lifesciences Ltd | 5.9% | 13D | Jan 15, 2026 | filing ↗ | |
| Zynext Ventures USA LLC | 5.9% | 13D | Jan 15, 2026 | filing ↗ | |
| Avicenna Life SCI Master Fund LP | exited | 13G | Jul 17, 2026 | filing ↗ | |
| Avicenna Life SCI Master GP LLC | exited | 13G | Jul 17, 2026 | filing ↗ | |
| ULYS, L.L.C. | exited | 13G | Jul 17, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jul 13, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jul 13, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 13, 2026 | filing ↗ |
| Other events (8.01) | Jul 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 13, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 29, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 16, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 12, 2026 | filing ↗ |
| Earnings (2.02) | May 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 11, 2026 | filing ↗ |
| Other events (8.01) | Mar 24, 2026 | filing ↗ |
| Earnings (2.02) | Mar 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 16, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | Jan 15, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jan 15, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 15, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 8, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 3, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Jan 3, 2026 | filing ↗ |
| Earnings (2.02) | Nov 10, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 10, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 8, 2025 | filing ↗ |
| New financial obligation (2.03) | Oct 8, 2025 | filing ↗ |
| Other events (8.01) | Sep 17, 2025 | filing ↗ |
| Earnings (2.02) | Aug 11, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 11, 2025 | filing ↗ |